# FDA Inspection 1042641 - Nomax Inc - February 01, 2018

Source: https://www.keypedia.com/records/fda_inspections/nomax-inc/95797153-fc9b-48a7-adbe-2ad6d2d1b71c
Source feed: FDA_Inspections

> FDA inspection 1042641 of Nomax Inc, February 01, 2018. Classification: Voluntary Action Indicated (VAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1042641
- Company Name: Nomax Inc
- Inspection Date: 2018-02-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1315328 - 2026-02-25
- FDA Inspection 1229313 - 2024-02-16
- FDA Inspection 1194330 - 2022-12-02
- [FDA Inspection 1180777 - 2022-06-24](https://www.keypedia.com/records/fda_inspections/nomax-inc/bb70c0df-3c37-4fb5-855f-06bcbdfd2347)
- [FDA Inspection 991448 - 2016-10-27](https://www.keypedia.com/records/fda_inspections/nomax-inc/9a6fd37f-c2e3-4328-9ea0-107da1894819)

Company: https://www.keypedia.com/companies/nomax-inc/269d696c-bdf9-48a2-9ce3-2ba71aef35aa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c